Robert L. Smith

15.2k total citations · 1 hit paper
303 papers, 11.2k citations indexed

About

Robert L. Smith is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Robert L. Smith has authored 303 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 52 papers in Pharmacology and 49 papers in Oncology. Recurrent topics in Robert L. Smith's work include Pharmacogenetics and Drug Metabolism (37 papers), Metabolism and Genetic Disorders (34 papers) and Drug Transport and Resistance Mechanisms (32 papers). Robert L. Smith is often cited by papers focused on Pharmacogenetics and Drug Metabolism (37 papers), Metabolism and Genetic Disorders (34 papers) and Drug Transport and Resistance Mechanisms (32 papers). Robert L. Smith collaborates with scholars based in United Kingdom, United States and Norway. Robert L. Smith's co-authors include R. T. Williams, Chi‐Sun Wang, P. Millburn, John Caldwell, Rashmi R. Shah, S. C. Mitchell, R. T. Williams, Colin T. Dolphin, Bernard M. Wagner and R. Ayesh and has published in prestigious journals such as Nature, Science and Journal of the American Chemical Society.

In The Last Decade

Robert L. Smith

299 papers receiving 10.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lowry determination of protein in the presence of Triton X-100

1975 733 citations Robert L. Smith et al. profile →

Peers

Countries citing papers authored by Robert L. Smith

Since Specialization

Citations

This map shows the geographic impact of Robert L. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Smith more than expected).

Fields of papers citing papers by Robert L. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Smith. The network helps show where Robert L. Smith may publish in the future.

Co-authorship network of co-authors of Robert L. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Smith. A scholar is included among the top collaborators of Robert L. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Smith. Robert L. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of the transcription factor nuclear factor 1 B T>C polymorphism on clozapine metabolism in vivo and expression of intestinal transporters in vitro 2025 ·Drug Metabolism and Disposition ·(unknown), Robert L. Smith, (unknown), (unknown), Inger Johansson, Magnus Ingelman‐Sundberg, Ole A. Andreassen, Espen Molden	0
2	Effect of the NFIB rs28379954 T>C polymorphism on CYP2D6‐catalyzed metabolism of solanidine 2024 ·Clinical and Translational Science ·Robert L. Smith, (unknown), Elisabet Størset, (unknown), Kevin S. O’Connell, (unknown), Magnus Ingelman‐Sundberg, Espen Molden	5
3	Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites—a study in 839 patients with known CYP2D6 genotype 2023 ·European Journal of Clinical Pharmacology ·(unknown), Elisabet Størset, Marianne Kristiansen Kringen, Espen Molden, Robert L. Smith	15
4	Evidence for solanidine as a dietary CYP2D6 biomarker: Significant correlation with risperidone metabolism 2023 ·British Journal of Clinical Pharmacology ·(unknown), Robert L. Smith, Marianne Kristiansen Kringen, Magnus Ingelman‐Sundberg, Espen Molden, Elisabet Størset	12
5	Plasma potassium concentration and cardiac repolarisation markers, Tpeak–Tend and Tpeak–Tend/QT, during and after exercise in healthy participants and in end-stage renal disease 2022 ·European Journal of Applied Physiology ·(unknown), (unknown), Claus Graff, (unknown), Jørgen K. Kanters, Robert L. Smith, Aaron C. Petersen, Keld Kjeldsen, Michael J. McKenna	7
6	European Whites May Need Lower Minimum Therapeutic Clozapine Doses Than Those Customarily Proposed 2021 ·Journal of Clinical Psychopharmacology ·Georgios Schoretsanitis, Robert L. Smith, Espen Molden, Anssi Solismaa, Niko Seppälä, Miloslav Kopeček, (unknown), I. Cánovas Olmos, Marta Vázquez, Celso Iglesias García, (unknown), Edoardo Spina, José de León	19
7	Absolute and Dose-Adjusted Serum Concentrations of Clozapine in Patients Switching vs. Maintaining Treatment: An Observational Study of 1979 Patients 2021 ·CNS Drugs ·(unknown), Robert L. Smith, Øystein Karlstad, Ole A. Andreassen, Espen Molden	3
8	Impact of age and CYP2D6 genetics on exposure of aripiprazole and dehydroaripiprazole in patients using long-acting injectable versus oral formulation: relevance of poor and intermediate metabolizer status 2019 ·European Journal of Clinical Pharmacology ·(unknown), Espen Molden, Gudrun Høiseth, Christoph U. Correll, Robert L. Smith	16
9	Identification of FOXP2 Truncation as a Novel Cause of Developmental Speech and Language Deficits 2005 ·The American Journal of Human Genetics ·Kay MacDermot, Elena Bonora, Nuala Sykes, (unknown), Cecilia Lai, Sonja C. Vernes, Faraneh Vargha‐Khadem, Fiona McKenzie, Robert L. Smith, Anthony P. Monaco, Simon E. Fisher	291
10	Risedronate increases bone mineral density and is well-tolerated in postmenopausal women with low bone mineral density 1999 ·Open Repository and Bibliography (University of Liège) ·C Ribot, Robert L. Smith, I. Fogelman, P. Bettica, Simon Pack, D Ethgen, Jean‐Yves Reginster	5
11	Risedronate produces dose-dependent increases in bone mineral density in postmenopausal women with low bone mass 1999 ·Open Repository and Bibliography (University of Liège) ·I. Fogelman, C Ribot, Robert L. Smith, P. Bettica, Simon Pack, D Ethgen, Jean‐Yves Reginster	2
12	The FEMA GRAS Assessment of trans-Anethole Used as a Flavouring Substance 1999 ·Food and Chemical Toxicology ·Paul M. Newberne, Robert L. Smith, John Doull, Jay I. Goodman, I.C. Munro, Philip S. Portoghese, Bernard M. Wagner, Carrol S. Weil, L.A. Woods, Timothy B. Adams, (unknown), R.A. Ford	101
13	The FEMA GRAS Assessment of Lactones Used as Flavour Ingredients 1998 ·Food and Chemical Toxicology ·Timothy B. Adams, (unknown), John Doull, I.C. Munro, Paul M. Newberne, Philip S. Portoghese, Robert L. Smith, Bernard M. Wagner, Carrol S. Weil, L.A. Woods, R.A. Ford	78
14	Synthesis and biological activity of ras farnesyl protein transferase inhibitors. Tetrapeptide analogs with amino methyl and carbon linkages 1994 ·Bioorganic & Medicinal Chemistry ·John Wai, (unknown), Thorsten E. Fisher, Samuel Graham, Robert L. Smith, W. Wayt Gibbs, Scott D. Mosser, Allen Oliff, David L. Pompliano, Elaine Rands, Nancy E. Kohl	23
15	Preoperative Evaluation of Cardiac Failure and Ischemia in Elderly Patients by Cardiopulmonary Exercise Testing 1993 ·CHEST Journal ·(unknown), Robert L. Smith, (unknown), (unknown)	236
16	The fish odour syndrome: biochemical, familial, and clinical aspects. 1993 ·BMJ ·R. Ayesh, S. C. Mitchell, (unknown), Robert L. Smith	97
17	3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 9. The synthesis and biological evaluation of novel simvastatin analogs 1992 ·Journal of Medicinal Chemistry ·George D. Hartman, Wasyl Halczenko, (unknown), (unknown), Robert L. Smith, Steven M. Pitzenberger, Susan L. Fitzpatrick, Alfred W. Alberts, R. Bostedor	8
18	Recent progress in the consideration of flavoring ingredients under the Food Additives Amendment. 15. GRAS substances. 1990 ·Food technology ·George A. Burdock, Bernard M. Wagner, Robert L. Smith, I.C. Munro, Paul M. Newberne	169
19	Influence of impaired renal function on the disposition of [14C]fazadinium in the anaesthetized greyhound [proceedings]. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·David R. Bevan, John Caldwell, J. D’Souza, Robert L. Smith	2
20	Sudden Onset of Psychosis in Association with Vitamin-B12 Deficiency 1967 ·BMJ ·Robert L. Smith, (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact